Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Persistent ED in Propecia users is not due to abnormal blood flow.

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Certain genetic variants increase the risk of aggressive prostate cancer.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

Finasteride and dutasteride are not recommended for feminizing therapy due to limited effectiveness and potential risks.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Finasteride helps with prostate symptoms but may cause sexual side effects.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Combining anastrozole with finasteride may better treat hormone imbalance in BPH.

Combining anastrozole with finasteride may better treat hormone imbalance in BPH.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Ginseng was more effective than finasteride in treating enlarged prostate in rats.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Finasteride may improve prostate cancer treatment outcomes.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Scutellaria baicalensis may help treat benign prostatic hyperplasia.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Injecting Platelet-Rich Plasma reduces leakage risk in colorectal surgery.

Gene variation affects prostate issues and hair loss.